Monitoring of Patients Receiving Menin Inhibitors for Acute Leukemia

This webinar from the Association for Molecular Pathology will cover menin inhibitors used in the treatment of acute leukemia. Menin inhibitors are targeted therapies for the treatment of genetically defined subsets of acute leukemia that led to clinical responses in refractory disease. However, as observed with other targeted therapies for cancer, on-target resistance mutations emerged in advanced cases following monotherapy. Therefore, combination strategies incorporating menin inhibitors are needed to improve durability and depth of remission.

To register, visit: https://educate.amp.org/local/catalog/view/product.php?productid=591.